Elizabeth H.Z. Thompson insider trades

Open-market stock purchases and sales by Elizabeth H.Z. Thompson, EVP, Head of Research & Dev at Acadia Pharmaceuticals Inc, from SEC Form 4 filings since Jul 1, 2021.

Recent trades

DateStockTradeValue
Jul 30, 2026ACAD Acadia Pharmaceuticals IncSold$431K
Jul 30, 2026ACAD Acadia Pharmaceuticals IncSold$1.3K
Jul 29, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 25, 2026ACAD Acadia Pharmaceuticals IncSold$73.7K
Mar 24, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—

Companies traded

  • ACAD Acadia Pharmaceuticals Inc: 3 sales, last Jul 30, 2026
  • IGMS IGM Biosciences, Inc: other filings, last Aug 14, 2025
  • HZNP Horizon Therapeutics Public Ltd Co: 6 sales, last Oct 6, 2023

Get free alerts when Elizabeth H.Z. Thompson files a new trade →